Status:
COMPLETED
The Delirium-CS Canada Study
Lead Sponsor:
St. Boniface Hospital
Collaborating Sponsors:
Foothills Medical Centre
Mazankowski Alberta Heart Institute
Conditions:
Delirium
Eligibility:
All Genders
Brief Summary
Delirium is a prevalent complication following cardiac surgery that is under-recognized using current methods of delirium detection and that may be better identified through a systematic and standardi...
Detailed Description
Delirium is an acute confusional state characterized by fluctuating mental status, inattention, and either disorganized thinking or altered level of consciousness. It has long been recognized as a com...
Eligibility Criteria
Inclusion
- All patients undergoing cardiac surgery who are admitted to an ICU or CSRU following their procedure
Exclusion
- Patients in whom delirium cannot be reliably identified (e.g., previous debilitating stroke, cerebral palsy, severe dementia, severe hearing disabilities or inability to understand English or French, active seizure disorder or Child-Pugh class B or C cirrhosis)
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
235 Patients enrolled
Trial Details
Trial ID
NCT02206880
Start Date
November 1 2014
End Date
July 1 2018
Last Update
August 16 2018
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Foothills Medical Centre
Calgary, Alberta, Canada, T2N 2T9
2
Mazankowski Alberta Heart Institute
Edmonton, Alberta, Canada, T6G 2B7
3
St. Boniface General Hospital
Winnipeg, Manitoba, Canada, R3C 4J8
4
New Brunswick Heart Centre
Saint John, New Brunswick, Canada, E2L 4L4